Radium-223 therapy in symptomatic metastatic castrate resistant prostate cancer (mCRPC) – sequential use post-abiraterone/prednisolone
- Resource Type
- Abstract
- Source
- In
Clinical Oncology October 2019 31 Supplement 1:e10-e11 - Subject
- Language
- ISSN
- 0936-6555